Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FM171
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,614
Award facts
- Contract value 100% obligated
- $47,613.71 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $47,613.71 to AmerisourceBergen Drug Corp on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price contract, which carries no set-aside designation, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract involves pharmaceutical product delivery to support federal medical procurement needs, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor in the pharmaceutical supply chain for military and veteran healthcare systems.
This delivery order represents one of numerous task orders executed under AmerisourceBergen's comprehensive IDC with DLA valued at $999,999,999.00 through December 2026. The parent IDC functions as a global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The Defense Health Agency, U.S. Coast Guard, and other government healthcare systems utilize this flexible contract vehicle. AmerisourceBergen competes on a full and open basis for these federal awards, demonstrating its capability to meet government procurement requirements alongside potential competitors in DLA's Pharmaceutical Prime Vendor Global Program.
Quick answers
Who was awarded contract SPE2DU26FM171?
SPE2DU26FM171 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DU26FM171 worth?
The government has obligated $47,614 on SPE2DU26FM171.
Is contract SPE2DU26FM171 an order under another contract?
Yes. SPE2DU26FM171 is a delivery order under SPE2DU25D4118, an indefinite delivery contract.
Was contract SPE2DU26FM171 competed?
The extent of competition for SPE2DU26FM171 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award